Rising incidence of heart failure demands action.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

33 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Age dependent associations of risk factors with heart failure: pooled population based cohort study.BMJ (Clinical research ed.) · 2021
   Pooled it
2. The Prognostic Significance of Anemia in Patients With Heart Failure: A Meta-Analysis of Studies From the Last Decade.Frontiers in cardiovascular medicine · 2021
   Pooled it
3. The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart 'OMics' in AGEing (HOMAGE) randomized clinical trial.European heart journal · 2021
   Trial
4. Care and Outcomes of New-Onset Heart Failure Across Vulnerable Populations: Temporal Trends in Mortality and Treatment in a Danish Nationwide Cohort From 2003 to 2022.Journal of the American Heart Association · 2026
   Article
5. Detection of exercise intensity thresholds in patients with chronic heart failure based on correlation properties of heart rate variability.European journal of applied physiology · 2025
   Article
6. Characterization of human living myocardial slices culture-induced adaptations: a translational perspective.Journal of molecular and cellular cardiology plus · 2025
   Article
7. SGLT2 inhibitor with and without ALDosterone AntagonIst for heart failure with preserved ejection fraction: Design paper.ESC heart failure · 2025
   Article
8. Investigating the effect of forum-based training on self-care and life satisfaction in heart failure patients referred to Tehran Heart Center in 2021-2022.Journal of education and health promotion · 2025
   Article
9. Glycnsisitin A: A promising bicyclic peptide against heart failure that facilitates TFRC-mediated uptake of iron in cardiomyocytes.Acta pharmaceutica Sinica. B · 2024
   Article
10. Circular RNAs: a small piece in the heart failure puzzle.Functional & integrative genomics · 2024
    Review
11. Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing hearts.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
12. The annual economic burden incurred by heart failure patients in Vietnam: a retrospective analysis.Journal of pharmaceutical policy and practice · 2024
    Article
13. A comprehensive review of discovery and development of drugs discovered from 2020-2022.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Review
14. Role of copper homeostasis and cuproptosis in heart failure pathogenesis: implications for therapeutic strategies.Frontiers in pharmacology · 2024
    Review
15. Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990-2019.European heart journal. Quality of care & clinical outcomes · 2023
    Article
16. Serum Pharmacochemistry Combined with Network Pharmacology-Based Mechanism Prediction and Pharmacological Validation of Zhenwu Decoction on Alleviating Isoprenaline-Induced Heart Failure Injury in Rats.ACS omega · 2023
    Article
17. Benefits of sacubitril/valsartan use in patients with chronic heart failure after cardiac valve surgery: a single-center retrospective study.Journal of cardiothoracic surgery · 2023
    Article
18. Mesaconine alleviates doxorubicin-triggered cardiotoxicity and heart failure by activating PINK1-dependent cardiac mitophagy.Frontiers in pharmacology · 2023
    Article
19. Strategies for cost-effectiveness analysis of rehabilitation for older patients with acute heart failure.Cost effectiveness and resource allocation : C/E · 2022
    Article
20. Hypocalcemia as a cause of reversible heart failure: A case report and review of the literature.Annals of medicine and surgery (2012) · 2022
    Article

Corrections and comments

• Comment on
  Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals.2018

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as